BridgeMD
Compares treatment options for Hypertension
Official title Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
ClinicalTrials.gov ID: NCT07045623
What this study is testing
- What it's testing
- The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 80
You may be able to join if
- Patients registered in the Hanam City Hypertension and Diabetes Program
- Adults aged 30 to 80 years
- Individuals who have provided written informed consent to participate in the study
You likely can't join if
- Chronic kidney disease stage 4 or higher (eGFR \<30 mL/min/1.73m²)
- Patients with liver cirrhosis or severe liver disease
- Patients with a history of acute coronary syndrome within the past 6 months
- Pregnant or breastfeeding women Individuals with psychiatric disorders that may affect study participation
The study team makes the final eligibility decision.
Where it's taking place
- Gyeonggi-do, Suwon-si, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gyeonggi-do, Suwon-si, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.